Quick Answer
PROVECTUS BIOPHARMACEUTICALS, INC. reported Shares Outstanding of 420.28 million shares for fiscal year 2025.
PROVECTUS BIOPHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 420.28M | +0.0% |
| 2024 | 420.28M | +0.2% |
| 2023 | 419.52M | +0.0% |
| 2022 | 419.45M | +0.0% |
| 2021 | 419.45M | +5.2% |
| 2020 | 398.81M | +2.3% |
| 2019 | 389.89M | +1.4% |
| 2018 | 384.61M | +3.7% |
| 2017 | 370.96M | +1.7% |
| 2016 | 364.77M | +78.0% |
| 2015 | 204.98M | +10.9% |
| 2014 | 184.80M | +15.7% |
| 2013 | 159.75M | +34.9% |
| 2012 | 118.43M | +7.1% |
| 2011 | 110.60M | +21.1% |
| 2010 | 91.30M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 420.28M | +0.0% | +0.0% |
| June 30, 2025 | 420.28M | +0.2% | +0.0% |
| December 31, 2024 | 420.28M | +0.2% | +0.0% |
| September 30, 2024 | 420.28M | +0.2% | +0.2% |
| June 30, 2024 | 419.52M | +0.0% | +0.0% |
| March 31, 2024 | 419.52M | +0.0% | +0.0% |
| December 31, 2023 | 419.45M | -0.0% | -0.0% |
| September 30, 2023 | 419.52M | +0.0% | +0.0% |
- PROVECTUS BIOPHARMACEUTICALS, INC. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, PROVECTUS BIOPHARMACEUTICALS, INC.’s shares outstanding has grown by 360.3% (from 91.30 million shares to 420.28 million shares).
- The most recent figure is from PROVECTUS BIOPHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: